The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tagraxofusp and low-intensity chemotherapy for the treatment of CD123-positive relapsed or refractory acute myeloid leukemia.
 
Wooin Cho
No Relationships to Disclose
 
Ritika Dutta
Consulting or Advisory Role - Acuta Capital Partners
 
Veronica de Santiago
No Relationships to Disclose
 
Kyle Cobarrubias
No Relationships to Disclose
 
Jihyun Choi
Employment - Stanford University Health
Travel, Accommodations, Expenses - Stanford University Health
 
Emily Inlow
Employment - Stanford University Health
Research Funding - Stanford University Health
 
Blake Shaw
No Relationships to Disclose
 
Kristen Cunanan
Employment - Mnemo Therapeuticsmo (I)
Leadership - Azalea therapeutics (I)
Stock and Other Ownership Interests - Azalea therapeutics (I)
Honoraria - Fred hutch (I)
Consulting or Advisory Role - Azalea therapeutics (I); Mnemo Therapeutics (I)
Research Funding - University of California, San Francisco (I)
Patents, Royalties, Other Intellectual Property - Memorial Sloan-Kettering Cancer Center (I); University of California, San Francisco (I)
Travel, Accommodations, Expenses - azalea therapeutics (I); Mnemo Therapeutics (I)
 
Vivek Charu
No Relationships to Disclose
 
Asiri Ediriwickrema
Patents, Royalties, Other Intellectual Property - Nanosive
 
Tian Zhang
No Relationships to Disclose
 
Gabriel Mannis
Consulting or Advisory Role - Abbvie/Genentech; Astellas Pharma; Bristol-Myers Squibb/Celgene; Immunogen; Macrogenics; Orbital Therapeutics; Rigel; SERVIER; Stemline Therapeutics; Syndax; WUGEN, Inc.
Research Funding - Astex Pharmaceuticals (Inst); Bristol-Myers Squibb/Celgene (Inst); Forty Seven (Inst); Gilead Sciences (Inst); Glycomimetics (Inst); Immune-Onc Therapeutics (Inst); Immunogen (Inst); Jazz Pharmaceuticals (Inst); Syndax (Inst)